结缔组织病肺间质病变高分辨率CT分期的临床价值  

Clinical Value of HRCT in Staging Lung Interstitial Disease in Connective Tissue Diseases

作　　者：邱建国[1] 潘解萍[2] 喻少波[2] 邢伟[1] 聂建新[1] 

机构地区：[1]江苏省常州市第一人民医院苏州大学附属第三医院影像科,江苏常州213003 [2]江苏省常州市第一人民医院苏州大学附属第三医院免疫风湿科,江苏常州213003

出　　处：《实用放射学杂志》2008年第9期1188-1190,1193,共4页Journal of Practical Radiology

摘　　要：目的探讨结缔组织病(CTD)肺间质病变高分辨率CT(HRCT)分期的临床价值。方法对222例临床确诊患有CTD者行HRCT胸部扫描,依据HRCT是否有肺间质病变及其程度进行分期,并对各期疗效进行对照。结果222例CTD中,64例HRCT表现正常,为0期;158例HRCT上有不同程度的弥漫性肺间质病变表现,其中表现为1期的有107例,2期36例,3期15例。经临床治疗后对照,治疗效果与结缔组织病肺间质病变分期的关系有统计学意义。结论结缔组织病肺间质病变HRCT分期对临床治疗具有指导作用和有利于临床对疾病程度的判断。Objective To study the clinical value of HRCT in staging of lung interstitial disease（ LID ） in connective tissue disease （ CTD ）. Methods 222 patients with CTD confirmed clinically underwent HRCT scan. The staging of LID according to the HRCT features of LID were done and the therapeutic effect was compared between each stage. Results In 222 cases ,64 cases were negative on HRCT as stage 0,158 cases had disseminated LID in different degree,including stage Ⅰ in 107 ,stage Ⅱ in 36 and stage Ⅲ in 15. There were significant statistically between the therapeutic effect and staging of LID. Conclusion The staging of CTD with LID by HRCT is helpful for judging the extent of LID and clinical treatment.

关 键 词：肺 结缔组织病 肺间质病变 分期 体层摄影术 X线计算机 

分 类 号：R563[医药卫生—呼吸系统] R814.42[医药卫生—内科学]